Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liang Yan

Showing results (881-890 of 885) with videos related to

Pageof 89
Sort By:
You have reached the last page of results.This site can display upto 885 results.
Nature|March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancerWantong Yao, Johnathon L Rose, Wei Wang, et al.
Nature Medicine|March 6, 2019
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancerKirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.
Nature Medicine|June 3, 2020
Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancerKirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|August 15, 2021
Trends of epidemiological characteristics of traumatic spinal cord injury in China, 2009-2018Dingjun Hao, Jinpeng Du, Liang Yan, et al.
Science (New York, N.Y.)|September 7, 2023
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitorsXiangdong Lv, Xuan Lu, Jin Cao, et al.
Pageof 89

Showing results (881-890 of 885) with videos related to

Sort By:
Pageof 89
You have reached the last page of results.This site can display upto 885 results.
Nature|March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancerWantong Yao, Johnathon L Rose, Wei Wang, et al.
Nature Medicine|March 6, 2019
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancerKirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.
Nature Medicine|June 3, 2020
Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancerKirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|August 15, 2021
Trends of epidemiological characteristics of traumatic spinal cord injury in China, 2009-2018Dingjun Hao, Jinpeng Du, Liang Yan, et al.
Science (New York, N.Y.)|September 7, 2023
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitorsXiangdong Lv, Xuan Lu, Jin Cao, et al.
Pageof 89